If the rationale for delaying surgery is to wait for stent endothelization and safe cessation of dual antiplatelet therapy, it appears to be more appropriate to focus on the measurement of hs-cTnI (primary outcome) and the occurrence of myocardial injury or infarction and stent thrombosis/revascularization (secondary outcomes) to determine “stent to surgery” time [5,27]. Here, TNNI3 is linked to infarction.